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Colonization and persistence capacity of a multi-strain probiotic in food allergy. The purpose of our study was: 1) Evaluate the baseline presence of Bifidobacterium longum BB536 (BL), Bifidobacterium breve M-16V (BB) and Bifidobacterium infantis M-63 (BI) in children with IgE mediated CMA and/or EA, children sensitized but not allergic, healthy controls; before, during and after administration of multi-strain probiotics containing 3.5 3 10 9 UFC of BL, BB and BI (TribifÒ). METHODS: Infants aged 10-14 months, allergic to egg/milk (Group I) received TribifÒ for 30 days. Fecal samples at 0, 7, 15, 30, 60 and 90 days were evaluated by specific BL, BI and BB primers. Two control groups of egg/milk IgE-positive infants with negative food challenge (Group II) and IgE-negative healthy infants (Group III) were evaluated for BL, BI and BB in basal conditions. RESULTS: A total of 33 patients were then enrolled: 12 patients for Group 1, 11 for Group 2 and 10 for Group 3.At baseline, BL and BB were present in the order of 10 4 -10 5 cells/ul and TribifÒintake did not cause a significant increase during the time-course. At baseline, BI median concentration value was absent in the gut microbiota and its amount significantly increased from T 1 to T 3 . CONCLUSIONS: BL and BB are part of the normal bacterial microflora. A significant increase in BI concentration suggests that TribifÒ does colonize the intestinal tract with good persistence after discontinuation.
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